Multicenter RCT for BIliary Brushing: RX Cytology, BOSTON vs. Infinity®, US Endoscopy (BIB)
Primary Purpose
Biliary Stricture, Jaundice, Obstructive
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Biliary brushing with the RX Cytology brush, Boston Scientific
Biliary brushing with the Infinity® brush, US Endoscopy
Sponsored by
About this trial
This is an interventional diagnostic trial for Biliary Stricture
Eligibility Criteria
Inclusion Criteria:
- Patient admitted to one of the ERCP investigation centers with brushing and drainage for VBP stenosis (proximal or distal) during the study period
- Patient whose age is greater than or equal to 18 years and less than 90 years
- Patient ASA 1, ASA 2, ASA 3
- Lack of participation in another clinical study
- Signed informed consent
Exclusion Criteria:
- Patients admitted for ERCP for jaundice by lithiasic obstruction
- Patient under 18 or over 90
- Patient ASA 4, ASA 5
- Pregnant woman
- Patient (s) with coagulation abnormalities preventing puncture: TP <50%, Platelets <50,000 / mm3, effective anti-coagulation in progress, clopidogrel in progress
- Surgical setup (Billroth II, Roux en Y) preventing endoscopic access to the papilla
- Patient unable to give personal consent
- Lack of signed informed consent
Sites / Locations
- Clinique Paris Bercy
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Group A: RX Cytology brush, Boston Scientific FIRST
Group B: Infinity®, US Endoscopy FIRST
Arm Description
A first biliary brushing will be carried out during ERCP using a standard brush RX Cytology Brush, Boston Scientific, then a second brushing will be carried out using a brush INFINITY®, US Endoscopy
A first biliary brushing will be carried out during ERCP using an INFINITY® brush, US Endoscopy then a second brushing will be carried out using standard RX Cytology Brush, Boston Scientific
Outcomes
Primary Outcome Measures
Sensibility for adenocarcinoma
Rate of positive diagnosis of biliary brushing in case of cholangiocarcinoma stenosis
Secondary Outcome Measures
Sample abundance
Quantification of the cellular material obtained (acellular, weak, or abundant), presence of cellular cupboards unhooked by the brush or average number of cells per field
False negative
Negative brushing for a final diagnosis of cholangiocarcinoma
Predictive Negative Value
probability that patients with a negative brushing truly don't have cholangiocarcinoma
Feasibility of the 2 brushes: Analog visual scale
Analog visual scale: Feasibility scale (0 to 10, 0 for Extremely difficult to perform and 10 for very easy to perform)
Feasibility of the intra-biliary biopsies: Analog visual scale
Analog visual scale: Feasibility scale (0 to 10, 0 for Extremely difficult to perform and 10 for very easy to perform)
Feasibility of bile aspiration: Analog visual scale
Analog visual scale: Feasibility scale (0 to 10, 0 for Extremely difficult to perform and 10 for very easy to perform)
Feasibility of stenosis puncture under ultrasonography: Analog visual scale
Analog visual scale: Feasibility scale (0 to 10, 0 for Extremely difficult to perform and 10 for very easy to perform)
Full Information
NCT ID
NCT04251013
First Posted
January 25, 2020
Last Updated
June 17, 2022
Sponsor
Société Française d'Endoscopie Digestive
1. Study Identification
Unique Protocol Identification Number
NCT04251013
Brief Title
Multicenter RCT for BIliary Brushing: RX Cytology, BOSTON vs. Infinity®, US Endoscopy
Acronym
BIB
Official Title
Multicenter RCT Comparing Two Brushes of Different Diameters for Biliary Stenosis: RX Cytology Brush, BOSTON vs. Infinity® Brush, US Endoscopy. BIB Study (BIliary Brushing)
Study Type
Interventional
2. Study Status
Record Verification Date
June 2022
Overall Recruitment Status
Completed
Study Start Date
July 1, 2020 (Actual)
Primary Completion Date
March 1, 2022 (Actual)
Study Completion Date
March 1, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Société Française d'Endoscopie Digestive
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of this prospective national multicenter randomized study is to compare, during an ERCP for VBP stenosis, the sensitivity of two biliary brushes: the INFINITY® vs the RX Cytology Brush® The main objective is the comparison of the rates of positive diagnosis of biliary brushing in cases of adenocarcinoma stenosis The total number of subjects required: 50 (25 patients per group) Duration of the inclusion period: 2 years Duration of participation for each subject: from 7 days to 12 months (in case of negative initial withdrawal) Total duration of the study: 3 years
Detailed Description
The aim of this study is to compare, during an ERCP for VBP stenosis, the sensitivity of two biliary brushes: the INFINITY® vs the RX Cytology Brush®
OBJECTIVES
Main objective: Comparison of the rates of positive diagnosis of biliary brushing in cases of adenocarcinoma stenosis
Secondary objective (s):
Comparison of the quantification of the cellular material obtained (acellular, weak, or abundant), and the presence of cellular cupboards unhooked by the brush
Comparison of the 2 brushes false negative rates, and negative predictive value for the diagnosis of adenocarcinoma
Evaluation of the variation in the profitability of brushing and other sampling techniques (intra-biliary biopsies, puncture, aspiration of bile) according to the presence of a tumor mass syndrome of more than 1 cm.
Evaluation of the variation in the profitability of brushing and other sampling techniques (intra-biliary biopsies, puncture, aspiration of bile) according to the site of the stenosis (distal vs proximal BPV: common bile duct or intrahepatic duct), with the cost effectiveness
Technical failure rate of brushing and other samples (intra-biliary biopsies, bile aspiration)
This study concerns adult subjects with stenosis of the main bile duct (common bile duct or common hepatic duct).
ENDOSCOPIC PROCEDURE
Deep catheterization of the biliary duct (whatever the access technique: by the papilla or by precut) and cross stenosis by the guide wire, then biliary dilation (6 to 8mm)
Randomization if the inclusion criteria are met
Biliary brushing successively with the 2 brushes in the order designated by randomization:
Performing a dozen back and forth movements in the stenosis
Aspiration, if possible of bile by the catheter of the brush for cytological analysis
The contents of the brush will be spread over 3 blades (numbered) then sectioned and placed in cytolit with the contents of the tubing of the brush flushed with a few cc of cytolit. Each brush in a numbered pot. Blades 1,2 and 3 +/- bile 1 joined to pot n ° 1; blades 4,5 and 6 +/- bile 2 joined to pot 2
In the event of technical failure (impossibility of accessing the stenosis with the first or second brush, impossibility of removing the brush), the patient will be considered to have failed for this brush (absence of pathological material brought back)
All possible sampling methods will also be taken to obtain the anatomopathological diagnosis: intra-biliary biopsies with adult or pediatric forceps, wire-guided or not, biopsy samples guided by choledochoscopy, puncture under endo-ultrasonography, bile aspiration after release of the biliary stent, according to the physician's habits.
EFFECTIVE The total number of subjects required: 50 (25 patients per group) Duration of the inclusion period: 2 years Duration of participation for each subject: from 7 days to 12 months (in case of negative initial withdrawal) Total duration of the study: 3 years
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Biliary Stricture, Jaundice, Obstructive
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
National prospective multicenter RCT
Masking
None (Open Label)
Allocation
Randomized
Enrollment
51 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Group A: RX Cytology brush, Boston Scientific FIRST
Arm Type
Active Comparator
Arm Description
A first biliary brushing will be carried out during ERCP using a standard brush RX Cytology Brush, Boston Scientific, then a second brushing will be carried out using a brush INFINITY®, US Endoscopy
Arm Title
Group B: Infinity®, US Endoscopy FIRST
Arm Type
Active Comparator
Arm Description
A first biliary brushing will be carried out during ERCP using an INFINITY® brush, US Endoscopy then a second brushing will be carried out using standard RX Cytology Brush, Boston Scientific
Intervention Type
Device
Intervention Name(s)
Biliary brushing with the RX Cytology brush, Boston Scientific
Intervention Description
Biliary brushing during ERCP:
Performing a dozen back and forth movements in the stenosis
Bile aspiration if possible, by the catheter of the brush for cytological analysis
The contents of the brush will be spread over 3 blades (numbered) then sectioned and placed in cytolit with the contents of the tubing of the brush flushed with a few cc of cytolit. Each brush in a numbered pot. Blades 1,2 and 3 +/- bile 1 joined to pot n ° 1; blades 4,5 and 6 +/- bile 2 joined to pot 2
In the event of technical failure (impossibility of accessing the stenosis with the first or second brush, impossibility of removing the brush), the patient will be considered to have failed for this brush (absence of pathological material brought back)
Intervention Type
Device
Intervention Name(s)
Biliary brushing with the Infinity® brush, US Endoscopy
Intervention Description
Biliary brushing during ERCP:
Performing a dozen back and forth movements in the stenosis
Bile aspiration if possible, by the catheter of the brush for cytological analysis
The contents of the brush will be spread over 3 blades (numbered) then sectioned and placed in cytolit with the contents of the tubing of the brush flushed with a few cc of cytolit. Each brush in a numbered pot. Blades 1,2 and 3 +/- bile 1 joined to pot n ° 1; blades 4,5 and 6 +/- bile 2 joined to pot 2
In the event of technical failure (impossibility of accessing the stenosis with the first or second brush, impossibility of removing the brush), the patient will be considered to have failed for this brush (absence of pathological material brought back)
Primary Outcome Measure Information:
Title
Sensibility for adenocarcinoma
Description
Rate of positive diagnosis of biliary brushing in case of cholangiocarcinoma stenosis
Time Frame
8 days to 1 year (if negative)
Secondary Outcome Measure Information:
Title
Sample abundance
Description
Quantification of the cellular material obtained (acellular, weak, or abundant), presence of cellular cupboards unhooked by the brush or average number of cells per field
Time Frame
8 days
Title
False negative
Description
Negative brushing for a final diagnosis of cholangiocarcinoma
Time Frame
1 year
Title
Predictive Negative Value
Description
probability that patients with a negative brushing truly don't have cholangiocarcinoma
Time Frame
1 year
Title
Feasibility of the 2 brushes: Analog visual scale
Description
Analog visual scale: Feasibility scale (0 to 10, 0 for Extremely difficult to perform and 10 for very easy to perform)
Time Frame
1 day
Title
Feasibility of the intra-biliary biopsies: Analog visual scale
Description
Analog visual scale: Feasibility scale (0 to 10, 0 for Extremely difficult to perform and 10 for very easy to perform)
Time Frame
1 day
Title
Feasibility of bile aspiration: Analog visual scale
Description
Analog visual scale: Feasibility scale (0 to 10, 0 for Extremely difficult to perform and 10 for very easy to perform)
Time Frame
1 day
Title
Feasibility of stenosis puncture under ultrasonography: Analog visual scale
Description
Analog visual scale: Feasibility scale (0 to 10, 0 for Extremely difficult to perform and 10 for very easy to perform)
Time Frame
1 day
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patient admitted to one of the ERCP investigation centers with brushing and drainage for VBP stenosis (proximal or distal) during the study period
Patient whose age is greater than or equal to 18 years and less than 90 years
Patient ASA 1, ASA 2, ASA 3
Lack of participation in another clinical study
Signed informed consent
Exclusion Criteria:
Patients admitted for ERCP for jaundice by lithiasic obstruction
Patient under 18 or over 90
Patient ASA 4, ASA 5
Pregnant woman
Patient (s) with coagulation abnormalities preventing puncture: TP <50%, Platelets <50,000 / mm3, effective anti-coagulation in progress, clopidogrel in progress
Surgical setup (Billroth II, Roux en Y) preventing endoscopic access to the papilla
Patient unable to give personal consent
Lack of signed informed consent
Facility Information:
Facility Name
Clinique Paris Bercy
City
Charenton-le-Pont
ZIP/Postal Code
F-94220
Country
France
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Multicenter RCT for BIliary Brushing: RX Cytology, BOSTON vs. Infinity®, US Endoscopy
We'll reach out to this number within 24 hrs